Fortrea Scientific Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.23%
(FY 2023)
- Profit -2.80%
(FY 2023)
- Ebitda -2.89%
(FY 2023)
- Net Worth 17.35%
(FY 2023)
- Total Assets 16.66%
(FY 2023)
About Fortrea Scientific
The Corporate was formerly known as Labcorp Scientific Services & Solutions Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rangarajan Narasimhan, Rishi Sharma, and David Cooper serve as directors at the Company.
- CIN/LLPIN
U72300PN2007PTC230189
- Company No.
170183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2007
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fortrea Scientific?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rangarajan Narasimhan  | Director | 24-Jul-2020 | Current |
| Rishi Sharma | Director | 11-Sep-2023 | Current |
David Cooper  | Director | 30-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Fortrea Scientific.
Fortrea Scientific Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.23% increase. The company also saw a slight decrease in profitability, with a 2.8% decrease in profit. The company's net worth Soared by an impressive increase of 17.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortrea Scientific?
In 2023, Fortrea Scientific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fortrea Development India Private LimitedActive 17 years 5 monthsRangarajan Narasimhan, Rishi Sharma and 1 more are mutual person
Fortrea Clinical Development Private LimitedActive 22 years 2 monthsRangarajan Narasimhan, Rishi Sharma and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fortrea Scientific?
Fortrea Scientific has a workforce of 1822 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortrea Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortrea Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
